1. Home
  2. RGEN vs BROS Comparison

RGEN vs BROS Comparison

Compare RGEN & BROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • BROS
  • Stock Information
  • Founded
  • RGEN 1981
  • BROS 1992
  • Country
  • RGEN United States
  • BROS United States
  • Employees
  • RGEN N/A
  • BROS N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • BROS Restaurants
  • Sector
  • RGEN Health Care
  • BROS Consumer Discretionary
  • Exchange
  • RGEN Nasdaq
  • BROS Nasdaq
  • Market Cap
  • RGEN 8.0B
  • BROS 7.6B
  • IPO Year
  • RGEN N/A
  • BROS 2021
  • Fundamental
  • Price
  • RGEN $126.50
  • BROS $73.73
  • Analyst Decision
  • RGEN Buy
  • BROS Strong Buy
  • Analyst Count
  • RGEN 12
  • BROS 15
  • Target Price
  • RGEN $172.67
  • BROS $78.27
  • AVG Volume (30 Days)
  • RGEN 815.5K
  • BROS 2.9M
  • Earning Date
  • RGEN 04-29-2025
  • BROS 05-07-2025
  • Dividend Yield
  • RGEN N/A
  • BROS N/A
  • EPS Growth
  • RGEN N/A
  • BROS 109.32
  • EPS
  • RGEN N/A
  • BROS 0.38
  • Revenue
  • RGEN $650,429,000.00
  • BROS $1,361,068,000.00
  • Revenue This Year
  • RGEN $13.93
  • BROS $26.31
  • Revenue Next Year
  • RGEN $14.35
  • BROS $23.86
  • P/E Ratio
  • RGEN N/A
  • BROS $191.83
  • Revenue Growth
  • RGEN 4.88
  • BROS 30.42
  • 52 Week Low
  • RGEN $102.97
  • BROS $26.96
  • 52 Week High
  • RGEN $182.52
  • BROS $86.88
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 44.61
  • BROS 70.63
  • Support Level
  • RGEN $123.10
  • BROS $58.20
  • Resistance Level
  • RGEN $135.47
  • BROS $65.14
  • Average True Range (ATR)
  • RGEN 6.98
  • BROS 2.59
  • MACD
  • RGEN -0.97
  • BROS 1.53
  • Stochastic Oscillator
  • RGEN 25.20
  • BROS 98.83

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About BROS Dutch Bros Inc.

Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company operated shops.

Share on Social Networks: